GUARDIAN PHRMCY SERVICES-A (GRDN) Fundamental Analysis & Valuation

NYSE:GRDN • US40145W1018

Current stock price

37.26 USD
+1.64 (+4.6%)
At close:
37.26 USD
0 (0%)
After Hours:

This GRDN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. GRDN Profitability Analysis

1.1 Basic Checks

  • GRDN had positive earnings in the past year.
  • GRDN had a positive operating cash flow in the past year.
  • GRDN had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years GRDN had a positive operating cash flow.
GRDN Yearly Net Income VS EBIT VS OCF VS FCFGRDN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

  • The Return On Assets of GRDN (11.93%) is better than 97.00% of its industry peers.
  • The Return On Equity of GRDN (23.92%) is better than 92.00% of its industry peers.
  • The Return On Invested Capital of GRDN (19.24%) is better than 93.00% of its industry peers.
Industry RankSector Rank
ROA 11.93%
ROE 23.92%
ROIC 19.24%
ROA(3y)-4.52%
ROA(5y)1.44%
ROE(3y)10.51%
ROE(5y)36.52%
ROIC(3y)N/A
ROIC(5y)N/A
GRDN Yearly ROA, ROE, ROICGRDN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 50 -50

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.40%, GRDN is in the better half of the industry, outperforming 71.00% of the companies in the same industry.
  • GRDN's Profit Margin has improved in the last couple of years.
  • With a Operating Margin value of 5.02%, GRDN perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of GRDN has grown nicely.
  • The Gross Margin of GRDN (20.21%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of GRDN has remained more or less at the same level.
Industry RankSector Rank
OM 5.02%
PM (TTM) 3.4%
GM 20.21%
OM growth 3Y-4.27%
OM growth 5Y2.31%
PM growth 3Y-4.47%
PM growth 5Y4.63%
GM growth 3Y-0.4%
GM growth 5Y0.23%
GRDN Yearly Profit, Operating, Gross MarginsGRDN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. GRDN Health Analysis

2.1 Basic Checks

  • GRDN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • GRDN has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for GRDN has been increased compared to 5 years ago.
  • GRDN has a better debt/assets ratio than last year.
GRDN Yearly Shares OutstandingGRDN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
GRDN Yearly Total Debt VS Total AssetsGRDN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • GRDN has an Altman-Z score of 11.34. This indicates that GRDN is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 11.34, GRDN belongs to the best of the industry, outperforming 97.00% of the companies in the same industry.
  • There is no outstanding debt for GRDN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.34
ROIC/WACC2.13
WACC9.02%
GRDN Yearly LT Debt VS Equity VS FCFGRDN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.3 Liquidity

  • GRDN has a Current Ratio of 1.38. This is a normal value and indicates that GRDN is financially healthy and should not expect problems in meeting its short term obligations.
  • GRDN's Current ratio of 1.38 is in line compared to the rest of the industry. GRDN outperforms 51.00% of its industry peers.
  • A Quick Ratio of 1.11 indicates that GRDN should not have too much problems paying its short term obligations.
  • GRDN's Quick ratio of 1.11 is in line compared to the rest of the industry. GRDN outperforms 46.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.11
GRDN Yearly Current Assets VS Current LiabilitesGRDN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. GRDN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 142.06% over the past year.
  • GRDN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 19.43% yearly.
  • GRDN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.93%.
  • GRDN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.50% yearly.
EPS 1Y (TTM)142.06%
EPS 3Y10.91%
EPS 5Y19.43%
EPS Q2Q%73.68%
Revenue 1Y (TTM)17.93%
Revenue growth 3Y16.81%
Revenue growth 5Y14.5%
Sales Q2Q%17.44%

3.2 Future

  • GRDN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.71% yearly.
  • Based on estimates for the next years, GRDN will show a small growth in Revenue. The Revenue will grow by 4.81% on average per year.
EPS Next Y37.1%
EPS Next 2Y24.23%
EPS Next 3Y22.71%
EPS Next 5YN/A
Revenue Next Year-1.77%
Revenue Next 2Y2.59%
Revenue Next 3Y4.81%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GRDN Yearly Revenue VS EstimatesGRDN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
GRDN Yearly EPS VS EstimatesGRDN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0 0.5 -0.5 1 -1

More info and screens

Find the best growth stocksShow best growing peers

3

4. GRDN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 48.39, which means the current valuation is very expensive for GRDN.
  • Compared to the rest of the industry, the Price/Earnings ratio of GRDN is on the same level as its industry peers.
  • GRDN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.54.
  • The Price/Forward Earnings ratio is 35.29, which means the current valuation is very expensive for GRDN.
  • GRDN's Price/Forward Earnings is on the same level as the industry average.
  • GRDN is valuated expensively when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 48.39
Fwd PE 35.29
GRDN Price Earnings VS Forward Price EarningsGRDN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • GRDN's Enterprise Value to EBITDA is on the same level as the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as GRDN.
Industry RankSector Rank
P/FCF 29.23
EV/EBITDA 24.13
GRDN Per share dataGRDN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • GRDN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • GRDN has a very decent profitability rating, which may justify a higher PE ratio.
  • GRDN's earnings are expected to grow with 22.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.3
PEG (5Y)2.49
EPS Next 2Y24.23%
EPS Next 3Y22.71%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GRDN Dividend Analysis

5.1 Amount

  • GRDN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GRDN Fundamentals: All Metrics, Ratios and Statistics

GUARDIAN PHRMCY SERVICES-A

NYSE:GRDN (3/23/2026, 8:04:00 PM)

After market: 37.26 0 (0%)

37.26

+1.64 (+4.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-11
Earnings (Next)05-11
Inst Owners57.1%
Inst Owner Change-0.95%
Ins Owners8.89%
Ins Owner Change77.34%
Market Cap2.36B
Revenue(TTM)1.45B
Net Income(TTM)49.22M
Analysts86
Price Target35.7 (-4.19%)
Short Float %8.14%
Short Ratio7.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.96%
Min EPS beat(2)-13.49%
Max EPS beat(2)29.41%
EPS beat(4)1
Avg EPS beat(4)-3.46%
Min EPS beat(4)-18.3%
Max EPS beat(4)29.41%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.33%
Min Revenue beat(2)0.17%
Max Revenue beat(2)4.48%
Revenue beat(4)4
Avg Revenue beat(4)1.88%
Min Revenue beat(4)0.17%
Max Revenue beat(4)4.48%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.94%
EPS NQ rev (1m)3.51%
EPS NQ rev (3m)3.51%
EPS NY rev (1m)0%
EPS NY rev (3m)15.86%
Revenue NQ rev (1m)-2.9%
Revenue NQ rev (3m)-2.9%
Revenue NY rev (1m)-1.57%
Revenue NY rev (3m)-2.24%
Valuation
Industry RankSector Rank
PE 48.39
Fwd PE 35.29
P/S 1.63
P/FCF 29.23
P/OCF 23.53
P/B 11.47
P/tB 21.94
EV/EBITDA 24.13
EPS(TTM)0.77
EY2.07%
EPS(NY)1.06
Fwd EY2.83%
FCF(TTM)1.27
FCFY3.42%
OCF(TTM)1.58
OCFY4.25%
SpS22.88
BVpS3.25
TBVpS1.7
PEG (NY)1.3
PEG (5Y)2.49
Graham Number7.5
Profitability
Industry RankSector Rank
ROA 11.93%
ROE 23.92%
ROCE 28.85%
ROIC 19.24%
ROICexc 26.02%
ROICexgc 55.01%
OM 5.02%
PM (TTM) 3.4%
GM 20.21%
FCFM 5.57%
ROA(3y)-4.52%
ROA(5y)1.44%
ROE(3y)10.51%
ROE(5y)36.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y6.92%
ROICexgc growth 5Y6.02%
ROICexc growth 3Y3.44%
ROICexc growth 5Y8.17%
OM growth 3Y-4.27%
OM growth 5Y2.31%
PM growth 3Y-4.47%
PM growth 5Y4.63%
GM growth 3Y-0.4%
GM growth 5Y0.23%
F-Score8
Asset Turnover3.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 87.51%
Cap/Sales 1.35%
Interest Coverage 111.85
Cash Conversion 105.49%
Profit Quality 163.98%
Current Ratio 1.38
Quick Ratio 1.11
Altman-Z 11.34
F-Score8
WACC9.02%
ROIC/WACC2.13
Cap/Depr(3y)83.37%
Cap/Depr(5y)81.5%
Cap/Sales(3y)1.36%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)142.06%
EPS 3Y10.91%
EPS 5Y19.43%
EPS Q2Q%73.68%
EPS Next Y37.1%
EPS Next 2Y24.23%
EPS Next 3Y22.71%
EPS Next 5YN/A
Revenue 1Y (TTM)17.93%
Revenue growth 3Y16.81%
Revenue growth 5Y14.5%
Sales Q2Q%17.44%
Revenue Next Year-1.77%
Revenue Next 2Y2.59%
Revenue Next 3Y4.81%
Revenue Next 5YN/A
EBIT growth 1Y215.55%
EBIT growth 3Y11.83%
EBIT growth 5Y17.15%
EBIT Next Year74.38%
EBIT Next 3Y30.11%
EBIT Next 5YN/A
FCF growth 1Y94.05%
FCF growth 3Y36.47%
FCF growth 5Y12.76%
OCF growth 1Y72.97%
OCF growth 3Y27.37%
OCF growth 5Y13.76%

GUARDIAN PHRMCY SERVICES-A / GRDN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for GUARDIAN PHRMCY SERVICES-A?

ChartMill assigns a fundamental rating of 6 / 10 to GRDN.


What is the valuation status of GUARDIAN PHRMCY SERVICES-A (GRDN) stock?

ChartMill assigns a valuation rating of 3 / 10 to GUARDIAN PHRMCY SERVICES-A (GRDN). This can be considered as Overvalued.


How profitable is GUARDIAN PHRMCY SERVICES-A (GRDN) stock?

GUARDIAN PHRMCY SERVICES-A (GRDN) has a profitability rating of 7 / 10.


What is the financial health of GUARDIAN PHRMCY SERVICES-A (GRDN) stock?

The financial health rating of GUARDIAN PHRMCY SERVICES-A (GRDN) is 7 / 10.